查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1738307

細胞分析市場－全球產業規模、佔有率、趨勢、機會及預測（按產品與服務、應用、最終用戶、地區及競爭細分，2020-2030 年）

Cell Based Assays Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Products & Services, By Application, By End User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年，全球細胞檢測市場規模達172.8億美元，預計2030年將達278.8億美元，複合年成長率達8.30%。由於針對慢性病和罕見疾病的創新療法需求不斷成長，該市場正呈現強勁成長勢頭。疫情期間治療藥物的採用率不斷提高，加之研發活動的加強，正加速市場擴張。全球醫療保健支出的不斷成長，加上藥物研發中對毒性篩選的需求日益成長，進一步推動了對細胞檢測的需求。這些檢測方法透過提高治療效率並降低藥物研發的成本和時間，為傳統檢測提供了可靠的替代方案。此外，人們對先進療法益處的認知日益加深，以及政府支持研究的舉措——例如美納里尼矽生物系統公司推出的用於多發性骨髓瘤血液分析的CELLSEARCH系統——正在提升市場到2030年的前景。

市場概覽
預測期 2026-2030
2024年市場規模 172.8億美元
2030年市場規模 278.8億美元
2025-2030 年複合年成長率 8.30%
成長最快的領域 藥物研發
最大的市場 北美洲

關鍵市場促進因素

日益重視藥物研發

主要市場挑戰

先進檢測技術成本高昂

主要市場趨勢

人工智慧與高內涵篩選的融合

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：臨床試驗分析

第6章：全球細胞分析市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按產品和服務（試劑、檢測試劑盒、微孔板、探針和標籤、細胞系、其他）
    • 按應用（臨床研究、藥物研發、其他）
    • 按最終用戶（生物技術和製藥公司、學術和研究機構、合約研究組織）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖
    • 按產品和服務
    • 按應用
    • 按最終用戶
    • 按地區

第7章：北美細胞分析市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第8章：歐洲細胞分析市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第9章：亞太細胞檢測市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 10 章：南美洲細胞分析市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 11 章：中東和非洲細胞分析市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 12 章：市場動態

  • 驅動程式
  • 挑戰

第13章：市場趨勢與發展

  • 最新動態
  • 併購
  • 產品發布

第 14 章：全球細胞分析市場：SWOT 分析

第 15 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品/服務的威脅

第 16 章：競爭格局

  • Corning, Inc.
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Lonza Group AG
  • Promega Corporation
  • F. Hoffmann-La Roche AG
  • Merck KGaA
  • Charles River Laboratories International, Inc.
  • Menarini Silicon Biosystems, Inc.

第 17 章：策略建議

第18章調查會社について,免責事項

簡介目錄
Product Code: 14420

The Global Cell Based Assays Market was valued at USD 17.28 billion in 2024 and is anticipated to reach USD 27.88 billion by 2030, expanding at a CAGR of 8.30%. This market is witnessing robust growth due to the rising demand for innovative therapeutics targeting chronic and rare diseases. Increased adoption of therapeutic drugs during outbreaks, coupled with intensified research and development activities, is accelerating market expansion. The rising healthcare expenditure globally, coupled with a growing need for toxicity screening in drug development, further contributes to the rising demand for cell-based assays. These assays offer a reliable alternative to traditional testing by improving treatment efficiency and reducing the cost and time associated with drug discovery. Furthermore, growing awareness of the benefits of advanced therapies and government initiatives to support research-such as the launch of CELLSEARCH by Menarini Silicon Biosystems for blood-based analysis of multiple myeloma-are enhancing the market's outlook through 2030.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 17.28 Billion
Market Size 2030USD 27.88 Billion
CAGR 2025-20308.30%
Fastest Growing SegmentDrug Discovery & Development
Largest MarketNorth America

Key Market Drivers

Growing Emphasis on Drug Discovery and Development

The expanding landscape of drug discovery is a key factor fueling the growth of the cell-based assays market. These assays play a pivotal role in evaluating drug efficacy and toxicity by mimicking cellular environments to yield physiologically relevant data. With pharmaceutical companies screening extensive compound libraries, the adoption of cell-based assays has become integral to preclinical studies. The FDA's approval of over 50 new drugs in 2023 highlights the active pace of drug development, where cell-based models accelerate lead identification while reducing dependency on animal testing. The ability of these assays to support precision medicine through patient-specific data makes them invaluable. Significant government funding, such as the NIH's $45 billion allocation in 2023, reinforces research in advanced screening technologies, driving the global uptake of cell-based assays as an accurate, ethical, and cost-effective solution in drug development pipelines.

Key Market Challenges

High Cost of Advanced Assay Technologies

A major obstacle in the cell-based assays market is the high cost associated with deploying advanced technologies. The acquisition and maintenance of sophisticated equipment like automated imaging systems, robotic handlers, and microplate readers demand large capital investments. Reagents, software, and consumables further add to operational costs. These financial demands can hinder adoption, especially among small research institutions, academic labs, and organizations in lower-income regions. Budget constraints in public institutions and uneven distribution of funding-largely concentrated in North America and Europe-amplify the challenge. Additionally, a shortage of trained personnel to operate complex systems and interpret intricate data creates further barriers. Without targeted support through technology-sharing initiatives, subsidized programs, or collaborative partnerships, the global adoption of these platforms may remain limited to wealthier regions.

Key Market Trends

Integration of Artificial Intelligence and High-Content Screening

A transformative trend in the market is the fusion of artificial intelligence (AI) with high-content screening (HCS) technologies. HCS platforms generate vast cellular datasets using automated imaging, which are now being analyzed using AI-driven tools that enhance accuracy and reduce human error. These algorithms facilitate faster, real-time interpretation of complex biological activities such as cell morphology and apoptosis, making drug screening more scalable and reliable. Government-backed research programs like the U.S. NAIRR initiative promote the use of AI in biomedical applications, including cell-based research. As labs seek efficiency, reproducibility, and scalability, the integration of AI with cell-based assay platforms is rapidly becoming a central element in modern drug screening and development strategies.

Key Market Players

  • Corning, Inc.
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Lonza Group AG
  • Promega Corporation
  • F. Hoffmann-La Roche AG
  • Merck KGaA
  • Charles River Laboratories International, Inc.
  • Menarini Silicon Biosystems, Inc.

Report Scope:

In this report, the Global Cell Based Assays Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Based Assays Market, By Product & Services:

  • Reagents
  • Assay Kits
  • Microplates
  • Probes & Labels
  • Cell Lines
  • Others

Cell Based Assays Market, By Application:

  • Clinical Research
  • Drug Discovery & Development
  • Others

Cell Based Assays Market, By End User:

  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Institutions
  • Contract Research Organizations

Cell Based Assays Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cell Based Assays Market.

Available Customizations:

Global Cell Based Assays Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Clinical Trial Analysis

  • 5.1. Ongoing Clinical Trials
  • 5.2. Completed Clinical Trials
  • 5.3. Terminated Clinical Trials
  • 5.4. Breakdown of Pipeline, By Development Phase
  • 5.5. Breakdown of Pipeline, By Status
  • 5.6. Breakdown of Pipeline, By Study Type
  • 5.7. Breakdown of Pipeline, By Region
  • 5.8. Clinical Trials Heat Map

6. Global Cell Based Assays Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Products & Services (Reagents, Assay Kits, Microplates, Probes & Labels, Cell Lines, Others)
    • 6.2.2. By Application (Clinical Research, Drug Discovery & Development, Others)
    • 6.2.3. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Contract Research Organizations)
    • 6.2.4. By Region
    • 6.2.5. By Company (2024)
  • 6.3. Market Map
    • 6.3.1. By Products & Services
    • 6.3.2. By Application
    • 6.3.3. By End User
    • 6.3.4. By Region

7. North America Cell Based Assays Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Products & Services
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Cell Based Assays Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Products & Services
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. Canada Cell Based Assays Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Products & Services
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. Mexico Cell Based Assays Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Products & Services
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User

8. Europe Cell Based Assays Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Products & Services
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Cell Based Assays Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Products & Services
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. Germany Cell Based Assays Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Products & Services
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. United Kingdom Cell Based Assays Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Products & Services
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. Italy Cell Based Assays Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Products & Services
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Spain Cell Based Assays Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Products & Services
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Asia-Pacific Cell Based Assays Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Products & Services
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Cell Based Assays Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Products & Services
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. India Cell Based Assays Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Products & Services
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Japan Cell Based Assays Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Products & Services
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User
    • 9.3.4. South Korea Cell Based Assays Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Products & Services
        • 9.3.4.2.2. By Application
        • 9.3.4.2.3. By End User
    • 9.3.5. Australia Cell Based Assays Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Products & Services
        • 9.3.5.2.2. By Application
        • 9.3.5.2.3. By End User

10. South America Cell Based Assays Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Products & Services
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Cell Based Assays Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Products & Services
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Argentina Cell Based Assays Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Products & Services
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Colombia Cell Based Assays Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Products & Services
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Middle East and Africa Cell Based Assays Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Products & Services
    • 11.2.2. By Application
    • 11.2.3. By End User
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Cell Based Assays Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Products & Services
        • 11.3.1.2.2. By Application
        • 11.3.1.2.3. By End User
    • 11.3.2. Saudi Arabia Cell Based Assays Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Products & Services
        • 11.3.2.2.2. By Application
        • 11.3.2.2.3. By End User
    • 11.3.3. UAE Cell Based Assays Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Products & Services
        • 11.3.3.2.2. By Application
        • 11.3.3.2.3. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

  • 13.1. Recent Developments
  • 13.2. Mergers & Acquisitions
  • 13.3. Product Launches

14. Global Cell Based Assays Market: SWOT Analysis

15. Porters Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Products/Services

16. Competitive Landscape

  • 16.1. Corning, Inc.
    • 16.1.1. Business Overview
    • 16.1.2. Company Snapshot
    • 16.1.3. Products & Services
    • 16.1.4. Financials (As Reported)
    • 16.1.5. Recent Developments
    • 16.1.6. Key Personnel Details
    • 16.1.7. SWOT Analysis
  • 16.2. Bio-Rad Laboratories, Inc.
  • 16.3. Thermo Fisher Scientific Inc.
  • 16.4. Danaher Corporation
  • 16.5. Lonza Group AG
  • 16.6. Promega Corporation
  • 16.7. F. Hoffmann-La Roche AG
  • 16.8. Merck KGaA
  • 16.9. Charles River Laboratories International, Inc.
  • 16.10. Menarini Silicon Biosystems, Inc.

17. Strategic Recommendations

18. About Us & Disclaimer